Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 35

    Indian American Pharma millionaire sent to 5.5 years imprisonment for bribery for pushing opioids

    Indian American Pharma millionaire sent to 5.5 years imprisonment for bribery for pushing opioids

    Medical Dialogues Bureau24 Jan 2020 10:30 AM IST
    Boston: The founder of an Arizona pharmaceutical company was ordered to spend 5 1/2 years in prison Thursday for orchestrating a bribery and kickback...
    Cipla gets USFDA observations for its Goa facility

    Cipla gets USFDA observations for its Goa facility

    Medical Dialogues Bureau23 Jan 2020 3:23 PM IST
    New Delhi: Drug firm Cipla on Wednesday said it has received observations from the USFDA for its Goa manufacturing facility. It further said that the...
    Alembic Pharma gets final USFDA nod for Fenofibrate tablets

    Alembic Pharma gets final USFDA nod for Fenofibrate tablets

    Medical Dialogues Bureau23 Jan 2020 2:56 PM IST
    New Delhi: Alembic Pharmaceuticals on Thursday said it has received final nod from the US health regulator for fenofibrate tablets, which reduces...
    Piramal Group to infuse Rs 500 crore in pharma operations in Telangana

    Piramal Group to infuse Rs 500 crore in pharma operations in Telangana

    Medical Dialogues Bureau23 Jan 2020 10:15 AM IST
    Hyderabad: Healthcare major Piramal Group has agreed to invest Rs 500 crore over the next three years in Telangana for setting up new facilities and...
    Japanese financial group MUFG sells 2.10pc shares in Cipla

    Japanese financial group MUFG sells 2.10pc shares in Cipla

    Medical Dialogues Bureau23 Jan 2020 10:00 AM IST
    "MUFG has sold an indirect interest in Cipla Ltd on account of sale of the following entities: First State Investment Management (UK) Ltd, First...
    Lupin Foundation Wins IDMA Corporate Citizen Award 2019

    Lupin Foundation Wins IDMA Corporate Citizen Award 2019

    Medical Dialogues Bureau23 Jan 2020 9:45 AM IST
    Mumbai: Pharma major Lupin Limited (Lupin) recently announced that its corporate social responsibility (CSR) arm, Lupin Foundation, has won the...
    Biocon Biologics gets Rs 536 crore investment from True North Fund

    Biocon Biologics gets Rs 536 crore investment from True North Fund

    Farhat Nasim22 Jan 2020 1:09 PM IST
    New Delhi: Biocon recently announced that Biocon Biologics India has received the subscription money aggregating to Rs. 536.25 crore from Activ Pine...
    GE South Asia gets Mahesh Palashikar as new President, CEO

    GE South Asia gets Mahesh Palashikar as new President, CEO

    Farhat Nasim22 Jan 2020 12:53 PM IST
    As a 20-year GE veteran, Mahesh Palashikar's career progressed through varied, complex assignments in manufacturing operations, global supply...
    Lupin concludes third edition of medical symposiums for Indian urology community

    Lupin concludes third edition of medical symposiums for Indian urology community

    Medical Dialogues Bureau22 Jan 2020 12:50 PM IST
    Mumbai: Pharma major Lupin Limited (Lupin) recently announced that it has successfully concluded the third edition of its series of medical symposiums...
    Glenmark offloads Indian gynaecology business for Rs 115 crore

    Glenmark offloads Indian gynaecology business for Rs 115 crore

    Medical Dialogues Bureau22 Jan 2020 11:39 AM IST
    New Delhi: In an attempt to drag down the financial burden, drug giant Glenmark Pharmaceuticals Limited (Glenmark) recently sold off...
    Novartis blockbuster Mayzent wins European nod for multiple sclerosis

    Novartis blockbuster Mayzent wins European nod for multiple sclerosis

    Medical Dialogues Bureau22 Jan 2020 11:25 AM IST
    The European marketing authorization makes Mayzent the first and only indicated oral treatment proven in SPMS patients with the active disease based...
    EC approves Roches Polivy combo in patients with previously treated aggressive lymphoma

    EC approves Roche's Polivy combo in patients with previously treated aggressive lymphoma

    Medical Dialogues Bureau22 Jan 2020 11:01 AM IST
    Roche announced that the European Commission has granted conditional marketing authorisation for Polivy® (polatuzumab vedotin), in combination with...
    PrevNext

    Popular Stories

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by...

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok